drugset
drugset / Trial / NCT03011450

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

NCT03011450 ↗

Phase 3 Completed 471 enrolled Kowa Research Institute, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of K-877 in adult patients With Fasting High Triglyceride Levels ≥500 mg/dL and \<2000 mg/dL and Mild or Moderate Renal Impairment.

Timeline

Start
2016-11-26
Primary completion
2019-07-05
Completion
2019-07-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fenofibrate Small molecule — —
Comparator K-877 Unknown — —

Indications

No indication recorded.